New inhaler boosts exercise in COPD patients?
NCT ID NCT06067828
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times
Summary
This study tested whether a triple-combination inhaler (BGF MDI) helps people with moderate to severe COPD breathe better and exercise longer compared to a placebo or a dual-combination inhaler. 171 adults aged 40-80 took part. The main focus was on how well the lungs work during physical activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Greenville, South Carolina, 29615, United States
-
Research Site
Spartanburg, South Carolina, 29303, United States
-
Research Site
Edmonton, Alberta, T6G 2B7, Canada
-
Research Site
Kingston, Ontario, K7L 2V7, Canada
-
Research Site
Sainte-Foy, Quebec, G1V 4G5, Canada
-
Research Site
Guangzhou, 510163, China
-
Research Site
Nanchang, 330006, China
-
Research Site
Shenyang, 110001, China
-
Research Site
Zhengzhou, 450000, China
-
Research Site
Berlin, 12159, Germany
-
Research Site
Berlin, 14050, Germany
-
Research Site
Frankfurt, 60596, Germany
-
Research Site
Großhansdorf, 22927, Germany
-
Research Site
Hanover, 30449, Germany
-
Research Site
Heidelberg, 69115, Germany
-
Research Site
Lübeck, 23552, Germany
-
Research Site
Mainz, 55128, Germany
-
Research Site
Daegu, 42415, South Korea
-
Research Site
Seoul, 02447, South Korea
-
Research Site
Seoul, 05030, South Korea
-
Research Site
Benalmádena, 29630, Spain
-
Research Site
Madrid, 28007, Spain
-
Research Site
Santiago de Compostela, 15706, Spain
-
Research Site
Seville, 41013, Spain
-
Research Site
Leicester, LE1 5WW, United Kingdom
-
Research Site
London, SW3 6HP, United Kingdom
-
Research Site
London, W1T 6AH, United Kingdom
-
Research Site
Manchester, M23 9GP, United Kingdom
-
Research Site
Los Angeles, California, 90095, United States
-
Research Site
Tarzana, California, 91356, United States
-
Research Site
Torrance, California, 90502, United States
-
Research Site
Brooksville, Florida, 34613, United States
-
Research Site
Anderson, South Carolina, 29621, United States
Conditions
Explore the condition pages connected to this study.